Omnicell’s updated analyst narrative keeps the modeled fair value steady at US$57.43, even as some price targets are being revised in different directions. On one side, bullish analysts point to the ...
Powered by OmniSphere, Titan XT is built to support evolving healthcare needs while delivering greater pharmacy control and nursing confidence for a growing enterprise FORT WORTH, Texas--(BUSINESS ...
Raises full year 2025 total revenues, non-GAAP EBITDA and non-GAAP EPS guidance FORT WORTH, Texas--(BUSINESS WIRE)-- Omnicell, Inc. (“Omnicell,” “we,” “our ...
FORT WORTH, Texas--(BUSINESS WIRE)-- Omnicell, Inc. (OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the third quarter 2025, before ...
Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the fourth quarter and full year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results